No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
Acetate |
Acetate |
- |
- |
- |
40件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 70, 71, 73, 75, 76, 78, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 235, 265, 288, 298, 299 |
2 |
Advate |
- |
- |
- |
- |
1件: 288 |
3 |
Alphanate sd/ht |
- |
- |
- |
- |
1件: 288 |
4 |
Alphanate*inf 1f 1000ui+f 10ml |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
5 |
Alphanate*inf 1f 1500ui+f 10ml |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
6 |
Alphanate*inf 1f 250ui+f 5ml |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
7 |
Alphanate*inf 1f 500ui+f 5ml |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
8 |
Antihemophilic factor (recombinant) |
- |
- |
- |
- |
1件: 288 |
9 |
Apcc, apcc + txa |
- |
- |
- |
- |
1件: 288 |
10 |
Arc 1779 |
- |
- |
- |
- |
2件: 64, 288 |
11 |
Arc1779 |
- |
- |
- |
- |
2件: 64, 288 |
12 |
Arc1779 injection |
- |
- |
- |
- |
2件: 64, 288 |
13 |
Biostate |
- |
- |
- |
- |
1件: 288 |
14 |
Biostate® |
- |
- |
- |
- |
1件: 288 |
15 |
Blood coagulation factor viii and vwf, human |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
16 |
Blood sample |
- |
- |
- |
- |
12件: 8, 13, 46, 49, 51, 53, 61, 66, 97, 274, 288, 299 |
17 |
Bortezomib |
Bortezomib |
D03150 |
1件: PSMB5 |
1件: Proteasome |
13件: 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
18 |
Catridecacog |
Catridecacog |
D10532 |
- |
- |
2件: 97, 288 |
19 |
Chloride |
Chloride ion |
- |
- |
- |
17件: 6, 11, 13, 14, 34, 46, 51, 96, 97, 127, 168, 193, 227, 228, 288, 297, 299 |
20 |
Coagulation factor viii |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
21 |
Coagulation proteins |
- |
- |
- |
- |
1件: 288 |
22 |
Cyclophosphamide |
Cyclophosphamide |
D00287, D07760 |
- |
- |
43件: 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 61, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 |
23 |
Ddavp |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
2件: 75, 288 |
24 |
Ddavp (desmopressin) |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
1件: 288 |
25 |
Desmopressin |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
5件: 6, 64, 72, 225, 288 |
26 |
Desmopressin acetate |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
2件: 64, 288 |
27 |
Eqwilate |
- |
- |
- |
- |
1件: 288 |
28 |
F8vr |
- |
- |
- |
- |
1件: 288 |
29 |
Factane 200 iu/ml |
- |
- |
- |
- |
1件: 288 |
30 |
Factor viii |
- |
- |
- |
- |
1件: 288 |
31 |
Factor viii concentrate |
Antihemophilic factor human |
- |
- |
- |
1件: 288 |
32 |
Fanhdi |
- |
- |
- |
- |
1件: 288 |
33 |
Fanhdi 250ui*1f 250ui+f 10ml |
- |
- |
- |
- |
1件: 288 |
34 |
Fanhdi*inf fl 250ui+sir solv+s |
- |
- |
- |
- |
1件: 288 |
35 |
Fanhdi*inf fl 500ui+sir solv+s |
- |
- |
- |
- |
1件: 288 |
36 |
Fanhdi*inf fl1000ui+sir solv+s |
- |
- |
- |
- |
1件: 288 |
37 |
Fibrinogen |
Fibrinogen human |
- |
- |
- |
3件: 14, 65, 288 |
38 |
Fibrogammin |
Fibrinolysin |
D07422 |
- |
- |
2件: 51, 288 |
39 |
Fibrogammin p |
Fibrinolysin |
D07422 |
- |
- |
1件: 288 |
40 |
Fxiii concentrate (human) |
- |
- |
- |
- |
1件: 288 |
41 |
Fxiii concentrate (human) (fxiii) |
- |
- |
- |
- |
1件: 288 |
42 |
Haemate p |
- |
- |
- |
- |
1件: 288 |
43 |
Haemate p® (human coagulation factor viii) |
Antihemophilic factor human |
- |
- |
- |
1件: 288 |
44 |
Haemate-p, wilate |
- |
- |
- |
- |
1件: 288 |
45 |
Haemate® p 250 |
- |
- |
- |
- |
1件: 288 |
46 |
Hemofix |
- |
- |
- |
- |
1件: 288 |
47 |
Human coagulation factor viii |
Antihemophilic factor human |
- |
- |
- |
1件: 288 |
48 |
Human coagulation factor viii / von willebrand factor |
Antihemophilic factor human |
- |
- |
- |
1件: 288 |
49 |
Human coagulation factor viii associated with von willebrand factor (vwf) |
Antihemophilic factor human |
- |
- |
- |
1件: 288 |
50 |
Human coagulation factor viii, von willebrand factor complex |
Antihemophilic factor human, Von willebrand factor human |
- |
- |
- |
1件: 288 |
51 |
Human von willebrand factor |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
52 |
Human vwf/fviii concentrate |
- |
- |
- |
- |
1件: 288 |
53 |
Humate-p |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
54 |
Il-11 |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
1件: 288 |
55 |
Interleukin 11 |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
1件: 288 |
56 |
Interleukin-11 |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
2件: 96, 288 |
57 |
Marketed plasma-derived vwf/fviii concentrate |
- |
- |
- |
- |
1件: 288 |
58 |
Minirin |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
2件: 64, 288 |
59 |
Minrin |
- |
- |
- |
- |
1件: 288 |
60 |
Natriumchlorid |
Sodium chloride |
D02056 |
- |
- |
1件: 288 |
61 |
Natriumchlorid 0,9 % |
Sodium chloride |
D02056 |
- |
- |
1件: 288 |
62 |
Neumega (oprelvekin, interleukin 11, il-11) |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
1件: 288 |
63 |
Nn 1841 |
- |
- |
- |
- |
1件: 288 |
64 |
Nn1841 |
- |
- |
- |
- |
1件: 288 |
65 |
Obi-1 |
- |
- |
- |
- |
1件: 288 |
66 |
Obizur |
Susoctocog alfa |
D10831 |
- |
- |
1件: 288 |
67 |
Octocog alfa |
- |
- |
- |
- |
1件: 288 |
68 |
Octostim |
- |
- |
- |
- |
2件: 64, 288 |
69 |
Oprelvekin |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
1件: 288 |
70 |
Oprelvekin, interleukin 11, il-11 |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
1件: 288 |
71 |
Optivate |
- |
- |
- |
- |
1件: 288 |
72 |
Optivate® (human coagulation factor viii) |
Antihemophilic factor human |
- |
- |
- |
1件: 288 |
73 |
Physiologische kochsalzlösung fresenius - infusionslösung |
- |
- |
- |
- |
1件: 288 |
74 |
Phytomenadione |
Phylloquinone |
D00148 |
- |
- |
1件: 288 |
75 |
Plasma-derived fviii/vwf concentrate |
- |
- |
- |
- |
1件: 288 |
76 |
Prednisone |
Prednisone |
D00473 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
43件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
77 |
Prothrombin |
Prothrombin |
- |
- |
- |
1件: 288 |
78 |
Prothrombin complex concentrate |
Prothrombin |
- |
- |
- |
1件: 288 |
79 |
Recombinant factor viiii (rfviii) |
- |
- |
- |
- |
1件: 288 |
80 |
Recombinant factor xiii (rfxiii) |
- |
- |
- |
- |
2件: 97, 288 |
81 |
Recombinant interleukin-11 |
Oprelvekin |
D05266 |
1件: IL11RA |
3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
1件: 288 |
82 |
Recombinant von willebrand factor |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
83 |
Recombinant von willebrand factor (rvwf) |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
84 |
Recombinant von willebrand factor : recombinant fviii (rvwf:rfviii) |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
85 |
Rfviia |
Coagulation factor viia recombinant human |
D00172 |
- |
- |
1件: 288 |
86 |
Rfviia, rfviia + txa |
Coagulation factor viia recombinant human |
D00172 |
- |
- |
1件: 288 |
87 |
Rfviii |
- |
- |
- |
- |
1件: 288 |
88 |
Rituxan |
Rituximab |
D02994 |
1件: MS4A1 |
1件: Hematopoietic cell lineage |
4件: 46, 60, 256, 288 |
89 |
Rituximab |
Rituximab |
D02994 |
1件: MS4A1 |
1件: Hematopoietic cell lineage |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
90 |
Rvwf |
- |
- |
- |
- |
1件: 288 |
91 |
Saline solution |
- |
- |
- |
- |
4件: 2, 34, 288, 299 |
92 |
Sodium chloride |
Sodium chloride |
D02056 |
- |
- |
13件: 6, 11, 13, 14, 34, 46, 51, 168, 193, 227, 228, 288, 299 |
93 |
Sodium chloride solution 0.9% |
Sodium chloride |
D02056 |
- |
- |
1件: 288 |
94 |
Standard of care fviii replacement therapy |
- |
- |
- |
- |
1件: 288 |
95 |
Steroid |
- |
- |
- |
- |
1件: 288 |
96 |
Tranexamic acid |
Tranexamic acid |
D01136 |
1件: PLG |
4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
5件: 46, 70, 215, 227, 288 |
97 |
Von willebrand factor |
Von willebrand factor human |
- |
- |
- |
2件: 64, 288 |
98 |
Von willebrand factor (recombinant) |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
99 |
Von willebrand factor and coagulation factor viii in combination |
Beroctocog alfa |
- |
- |
- |
1件: 288 |
100 |
Von willebrand factor antigen |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
101 |
Von willebrand factor ristocetin cofactor |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
102 |
Von willebrand faktor |
- |
- |
- |
- |
1件: 288 |
103 |
Voncento |
- |
- |
- |
- |
1件: 288 |
104 |
Voncento, biostate® |
- |
- |
- |
- |
1件: 288 |
105 |
Vwd factor viii concentrate |
- |
- |
- |
- |
1件: 288 |
106 |
Vwf replacement therapy with wilate |
- |
- |
- |
- |
1件: 288 |
107 |
Vwf sd-35-dh |
- |
- |
- |
- |
1件: 288 |
108 |
Vwf/fviii products |
- |
- |
- |
- |
1件: 288 |
109 |
Wilate |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
110 |
Wilate 1000 |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
111 |
Wilate 500 |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
112 |
Wilate® 450 |
Von willebrand factor human |
- |
- |
- |
1件: 288 |
113 |
Wilfactin |
- |
- |
- |
- |
1件: 288 |
114 |
Willfact |
- |
- |
- |
- |
1件: 288 |
115 |
Wiloctin |
- |
- |
- |
- |
1件: 288 |